Xtant Medical Holdings (XTNT) Reports Q2 Loss of $0.54

Xtant Medical Holdings (NYSE: XTNT) reported Q2 EPS of ($0.54), versus ($0.37) reported last year. Revenue for the quarter came in at $21.4 million, versus $21.5 million reported last year.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c